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Abstract : Aims : We compared the clinicopathologic features of three types of 
colorectal serrated polyps, namely, hyperplastic polyps （HPs）, sessile serrated 
adenomas/polyps （SSA/Ps）, and traditional serrated adenomas （TSAs）, and 
analyzed the expression pattern of maspin in these serrated lesions.  We retro-
spectively examined 173 polypoid lesions that were endoscopically excised from 
136 patients and diagnosed as hyperplastic or adenomatous serrated lesions, 
and histologically classied as HPs, SSA/Ps, or TSAs.  Maspin expression was 
immunohistochemically examined in all lesions.  Overall, 59 lesions （34%） 
were classied as HPs, 70 （40%） as SSA/Ps and 44 （25%） as TSAs.  There 
were no significant differences in mean age or gender of patients between 
types, but SSA/Ps frequently developed on the right colon and showed a 
supercial/at elevation, whereas HPs and TSAs frequently developed on the 
left colon and showed protruded lesions.  The average diameters of HPs, SSA/
Ps, and TSAs were 7.2, 9.9, and 12.9 mm, respectively, showing significant 
differences.  Diffuse cytoplasmic expression of maspin was observed in the 
serrated glands of all three types.  In addition, focal or diffuse intranuclear 
localization of maspin was observed in 15% of HPs, 13% of SSA/Ps, and 
84% of TSAs, showing signicant differences between TSAs and the other two 
types.  The three types of serrated polyp examined in this study showed dis-
tinct clinicopathological features.  The presence of maspin expression in these 
polyps, regardless of whether they were hyperplastic or neoplastic, indicates 
that maspin might be commonly associated with cell proliferation, although the 
underlying mechanism might be different between types.
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Introduction
　Research on precancerous lesions of the colorectum has been intensively conducted, along 
with studies to improve endoscopic techniques and diagnostics for colorectal mucosal lesions. 
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Recently, a pathway through which cancer develops from colorectal serrated polyps has 
attracted attention in addition to the conventional theory, namely, the adenoma-carcinoma 
sequence1-3）.  Previously, colorectal serrated polyps were classied into hyperplastic polyps 
（HPs） and traditional serrated adenomas （TSAs）, but, in 2003, Goldstein et al 4） and Torla-
kovic et al 5） showed that some lesions previously diagnosed as HPs were adenomatous and 
proposed another type, the sessile serrated adenomas/polyp （SSA/P）.  Currently, there are 
two pathways considered in the pathogenesis of colorectal cancer, on the basis of a com-
bination of the above three serrated polyps : a traditional serrated pathway, in which HPs 
develop into cancer through TSAs, and a sessile serrated pathway, in which HPs develop 
into cancer through SSA/Ps 6，7）.
　However, a number of pathologists are still unsure about the diagnosis of SSA/Ps.  The 
main reason is the difficulty in distinguishing SSA/Ps from HPs histologically （Fig. 1）. 
Although SSA/Ps rarely show cellular atypia similar to HPs, they have structural atypias 
such as curved, meandering, branched （inverted T-shape, L-shape）, and dilated glands, mainly 
at the lower part of the gland, and are thereby distinguishable from HPs.  Moreover, prolif-
erative zones are located at the bottom of the gland for HPs, whereas they extend from the 
bottom to the surface of the gland for SSA/Ps.  These differential ndings, however, are not 
always clear in daily routine clinical specimens.  Currently, histological diagnostic standards 
developed by Higuchi et al 8，9）, on the basis of the reports by Torlakovic et al 5）, are gener-
ally used to diagnose SSA/Ps in Japan.
　Maspin is a unique member of the serpin family of protease inhibitors with tumor 
suppressive potential in several cancers10，11）.  The maspin gene was originally identied in 
normal mammary epithelial cells by subtractive hybridization on the basis of its mRNA 
expression.  It has tumor suppressive activity attributable to inhibition of cancer cell motility, 
Fig. 1.  Histological features of three types of serrated polyp.
Hyperplastic polyp （HP） is characterized by elongation of the crypts with mild 
serration. Sessile serrated adenoma/polyp （SSA/P） shows a dilated and distorted 
（multibranched） appearance to the crypts. Traditional serrated adenoma 
（TSA） consists of villous or serrated glands of tall-columnar epithelium with 
eosinophilic cytoplasm and pseudostratified nuclei.
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invasion and metastasis.  The regulatory mechanism of its expression in various cancer cells 
appears to involve DNA methylation and histone deacetylation which commonly play a sup-
pressive role in maspin gene activation 10，11）.  Recently, it has been demonstrated that down-
regulation of maspin expression correlates with progression and metastatic status in several 
cancers 10，11）.  We have also studied the expression pattern of maspin in the esophagus, 
stomach, colorectum, pancreas, and lung 11-17）, where a high rate of maspin expression is 
commonly observed during cancer formation from precancerous lesions, and maspin expres-
sion tends to be suppressed when invasion and metastasis of cancer cells occurs.  Similar 
results in the colorectum have been previously reported by several authors 18，19）.  However, 
to the best of our knowledge, there have been no reports focusing on maspin expression in 
colorectal serrated polyps.
　The purpose of this study was to compare the clinicopathological features of three 
colorectal serrated polyps, HPs, SSA/Ps, and TSAs, in patients treated in our hospital, and 
analyze the expression pattern of maspin and its signicance in these polyps.
Materials and Methods
　We studied 173 lesions that were endoscopically excised from 136 patients treated at 
Showa University Hospital between April 2008 and May 2010 which were diagnosed as 
hyperplastic or adenomatous serrated polyps.  These serrated polyps were classified into 
three histological types, i.e., HPs, SSA/Ps, and TSAs, on the basis of the World Health 
Organization （WHO） classication 20）, and the classication developed by Higuchi et al 8，9） 
（Fig. 1）.  In particular, HPs and SSA/Ps were distinguished on the basis of the seven items 
of Higuchi’s classication, as follows : （1） distinct serrated structure at the bottom of crypts 
and villous or papillary structure on the mucosal surface ; （2） multibranched or horizontally 
arrayed crypts ; （3） dilatation of crypts ; （4） increase in epithelium-to-interstitium ratio of at 
least 50% ; （5） nuclear division at the upper part of crypts ; （6） atypical cells at the upper 
part of crypts （enlarged nucleus with distinct nucleolus and balloon-like chromatin）; and （7） 
increase in production of mucus （within cells or lumen）.  Serrated polyps for which four or 
more of the seven items were observed were classied as SSA/Ps, and those for which three 
or less of the seven items were observed were classied as HPs.  These diagnoses were 
agreed upon by multiple observers （YO, NO, TM）.
　Clinicopathologically, ve items were investigated : age and gender of the patient, and the 
site, size, and macroscopic shape of the lesion.  The site was classied as the right or left 
colon.  The right colon included the cecum, ascending colon, and transverse colon, whereas 
the left colon included the descending colon, sigmoid colon, and rectum.  The size of the 
lesion was determined by the maximum diameter of the tumor in tissue samples.  The 
shape of the lesion was classied as one of two types, based on the Japanese Classication 
of Colorectal Carcinoma 21）: supercial elevated type （type IIa） or protruded type （types Ip, 
Isp, and Is）.
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　Immunohistochemical staining was performed using an avidin-biotin complex detection 
system （BenchMark XT/LT automated slide stainer ; Ventana Medical Systems, Inc., Tucson, 
AZ）.  Thin sections of 3μm were cut from the formalin-xed parafn-embedded blocks 
used for the histological analysis.  These slices were stained with anti-maspin monoclonal 
antibody （EAW24, Novocastra, Newcastle upon Tyne, UK ; dilution, 1 : 50） and subsequently 
observed under an optical microscope.  The positive control samples were myoepithelial cells 
of the mammary ducts.
　Statistical analyses were performed using the chi-square test and t test.  Differences with 
P-values＜ 0.05 were considered to be statistically signicant.
Results
Clinicopathological features
　Among the 173 lesions, 59 （34%） were classied as HPs, 70 （40%） as SSA/Ps, and 44 
（25%） as TSAs （Table 1）.  HPs and SSA/Ps showed no cellular atypia, whereas TSAs all 
showed mild or moderate cellular atypia.  The mean ages of the patients were in the range 
of 60～69 years for the three types, showing no signicant differences.  There was also no 
signicant gender difference.  On the other hand, the site of SSA/Ps was signicantly dif-
ferent from those of HPs and TSAs ; SSA/Ps were frequently developed in the right colon, 
whereas HPs and TSAs were frequently developed in the left colon.  The average diameters 
of HPs, SSA/Ps, and TSAs were 7.2, 9.9, and 12.9 mm, respectively, which were signicantly 
different.  Macroscopically, many SSA/Ps were supercially/atly elevated, whereas the major-
ity of HPs and TSAs were protruded, showing signicant differences （Table 1）.
Immunohistochemical features
　Diffuse cytoplasmic expression of maspin was observed throughout the glands of all 
Table 1.  Clinicopathological features of three types of serrated polyp
Serrated polyps p-value
HP
（n＝59）
SSA/P
（n＝70）
TSA
（n＝44） HP vs SSA/P SSA/P vs TSA HP vs TSA
Mean age （years） 60.2（32-81）
62.4
（36-84）
61.5
（29-85） NS NS NS
Gender （male : female） 50：9 52：18 29：15 NS NS NS
Site （right colon : left colon） 20：39 56：14 12：32 ＜ 0.01 ＜ 0.01 NS
Mean size （mm）  7.2（2.5-20）
 9.9
（ 3-24）
12.9
（ 4-40） ＜ 0.01 ＜ 0.05 ＜ 0.01
Shape （protruded : superficial elevated） 48：11 29：41 39：5 ＜ 0.01 ＜ 0.01 NS
HP, hyperplastic polyp ; SSA/P, sessile serrated adenoma/polyp ; TSA, traditional serrated adenoma
NS, not significant
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three types of polyps.  In addition, focal or diffuse intranuclear localization of maspin was 
observed in nine HPs （15%）, nine SSA/Ps （13%）, and 37 TSAs （84%）, showing signicant 
differences between TSAs and the other two types of polyps （Table 2, Fig. 2）.  Maspin 
expression was absent or weak in the intact normal epithelium of the background mucosa 
of all samples.
Discussion
　The specimens of this study were lesions excised by endoscopy.  This means that the 
lesions included those excised by different endoscopists on the basis of their own decision. 
Therefore, the clinicopathological features obtained in this study do not necessarily indicate 
the true characteristics of colorectal serrated polyps.  In particular, many small HPs, which 
account for the majority of colorectal serrated polyps, would have been excluded from the 
excisions.  This exclusion may have easily affected the data for the frequency, size, and 
macroscopic shape of lesions.  Moreover, the predominance of males seen in all polyp types 
in this study may also be affected by differences in the frequency of males and females 
who undergo endoscopic examination.  Nevertheless, the clinicopathological features of each 
Table 2.  Immunohistochemical results of maspin expression in the serrated polyps
　 Serrated polyps p-value
　 　 HP（n＝59）
SSA/P
（n＝70）
TSA
（n＝44） HP vs SSA/P SSA/P vs TSA HP vs TSA
Maspin
Cytoplasmic
59
（100％）
70
（100％）
44
（100％） NS NS NS
Nuclear
 9
（ 15％）
 9
（ 13％）
37
（ 84％） NS ＜ 0.01 ＜ 0.01
Fig. 2.  Immunohistochemical features of three types of serrated polyp.
Diffuse cytoplasmic expression of maspin is observed in all three types. In 
addition, intranuclear localization of maspin is prominent in the traditional 
serrated adenoma （TSA）. HP, hyperplastic polyp; SSA/P, sessile serrated 
adenoma/polyp.
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polyp obtained in this study were in agreement with those reported previously 20）.  Namely, 
HPs frequently develop in the left colon and are relatively small, SSA/Ps frequently develop 
in the right colon, are relatively large （10 mm diameter on average）, and are mostly super-
cially/atly elevated, while TSAs frequently develop in the left colon and are larger and 
mostly protrude.  These clinicopathological features seem to be very useful for the diagnosis 
of serrated polyps.
　This is the rst paper to investigate and discuss the expression of maspin in colorectal 
serrated polyps.  In previous studies we have demonstrated maspin expression at a high rate 
in several metaplastic, dysplastic, and precancerous lesions, such as esophageal dysplasia, gas-
tric intestinal metaplasia and adenoma, pancreatic intraepithelial neoplasia, intraductal papil-
lary-mucinous adenoma, and colorectal adenoma11-16）.  Zheng et al 18） and Boltze19） have also 
reported a high rate of maspin expression in specimens of colorectal adenomas.  Maspin 
expression is hardly observed in intact normal epithelium, and therefore is considered to 
be associated with the proliferative changes of colorectal polyps regardless of whether the 
lesions are hyperplastic or adenomatous, ordinary or serrated.
　Maspin acts as a tumor suppressor when overexpressed in aggressive cancer cell lines and 
is thought to inhibit carcinoma invasion, metastasis and angiogenesis and induce apoptosis10）, 
but its role in human cancer is controversial because in some studies maspin expression has 
been associated with a poor prognosis, whereas in others it is associated with a favorable 
outcome 22）.  Some investigators found that intranuclear localization of maspin is associ-
ated with improved survival and emphasized that the tumor suppressor activity of maspin 
might require nuclear localization 22-25）.  In addition, Bettstetter and colleagues 26） found that 
elevated nuclear maspin expression was closely correlated with high microsatellite instability. 
In this study of precancerous serrated lesions, the focal or diffuse intranuclear localization of 
maspin was exclusively observed in TSAs.  Its signicance and effect were unclear and we 
failed to nd a relationship between nuclear maspin expression and microsatellite instability 
in our specimens （data not shown）.  These ndings, however, indicate that nuclear maspin 
expression might be a key feature in the differential diagnosis of serrated polyps ; in addi-
tion it is important to consider the two serrated pathways （fraditional and sessile） in the 
pathogenesis of colorectal cancer.
　In conclusions, the three types of serrated polyp examined in this study showed distinct 
clinicopathological features.  Maspin expression was frequently observed in all types of 
polyps and was considered to be associated with cell proliferation, although the underlying 
mechanism might be different between different types of polyps.
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